ARC-F12

N/A

Report date: 2024/07/02 10:11:50
NME

Base Information

Drug NameARC-F12
Drug Alias NameARC AMG1ARO-AMG1ARO-F12
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAngiopoietin like 3 inhibitorsApolipoprotein C-III inhibitorsRNA interference
TargetsAngiopoietin like 3Apolipoprotein C-III
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrowhead Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A